BAYZF

Bayer Aktiengesellschaft | Cotação de Ações

Última atualização24/01/2025, 17:00:00

PreçoUS$ 22,03

Variação (dia)US$ 22,03 (0.00%)▼

Min. 52 SemanasUS$ 19,50

Máx. 52 SemanasUS$ 34,01

Capitalização de mercado--

Endereço: Kaiser-Wilhelm-Allee 1, Leverkusen, 51368

Telefone: 49 214 30 1

Funcionários: 96.931

Bayer A.G.BAYZF

US$ 22,03

+ 22,030%

24/01/2025 17:00:00

1D 7D 1M 3M 1A Tudo

Visão geral da empresa

Preço atualUS$ 22,03

Valor de mercado--

AberturaUS$ 21,70

Preço máximoUS$ 22,45

Preço mínimoUS$ 22,45

VolumeUS$ 500

Fechamento anterior--

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment provides breeding, propagation, and production/processing of seeds, including seed dressing. It has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases; and collaboration and license agreement with Cytokinetics for the development and commercialization of aficamten. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company was founded in 1863 and is headquartered in Leverkusen, Germany.

Ações relacionadas

DSKYF,CHGCY,BFFAF,NVSEF,SNYNF

DSKYF,CHGCY,BFFAF,NVSEF,SNYNF ▼0.00% | R$ 0,00

Explore os ativos do mercado financeiro em tempo real com a nossa API

A API da brapi proporciona uma visão dos ativos do mercado financeiro. Com gráficos interativos e dados atualizados, oferecemos uma análise abrangente das tendências do mercado. Os desenvolvedores podem personalizar os módulos, configurar o range de tempo e escolher todos os dados necessários para decisões informadas.

Assine nossa newsletter para receber atualizações gratuitas por e-mail

Mantenha-se informado assinando nossa newsletter. Receba atualizações gratuitas por e-mail, incluindo rendimentos, novidades do mercado e insights valiosos. Estamos comprometidos em fornecer informações relevantes diretamente à sua caixa de entrada.

Conheça os Planos e Preços personalizados para acessar recursos exclusivos

Explore nossos Planos e Preços para obter acesso a recursos exclusivos, atendendo às suas necessidades específicas. Oferecemos opções flexíveis para investidores de todos os níveis, garantindo que você tenha as ferramentas certas para otimizar sua estratégia de investimento.